Published in Medicine (Baltimore) on January 01, 1990
Brain and high metabolic rate organ mass: contributions to resting energy expenditure beyond fat-free mass. Am J Clin Nutr (2010) 1.06
Failed rapid sequence induction in an achondroplastic dwarf. Indian J Anaesth (2011) 0.78
Bioenergetics and body compositional variables of humans. Trans Am Clin Climatol Assoc (1991) 0.75
Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet (1999) 8.53
Effects of cardiogenic shock on lactate and glucose metabolism after heart surgery. Crit Care Med (2000) 2.49
Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes (1999) 2.14
Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes (2007) 2.13
Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes (1990) 2.00
Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci U S A (1996) 1.80
Protein, fat, and carbohydrate requirements during starvation: anaplerosis and cataplerosis. Am J Clin Nutr (1998) 1.73
The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest (1999) 1.72
An independent assessment of two clubfoot-classification systems. J Pediatr Orthop (1998) 1.66
A reappraisal of the caloric requirements of men. Am J Clin Nutr (1987) 1.64
Suppression of alcohol-induced hypertension by dexamethasone. N Engl J Med (1995) 1.58
Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes (1996) 1.51
Reassessment of body mass indices. Am J Clin Nutr (1990) 1.51
Hepatic nonoxidative disposal of an oral glucose meal in patients with liver cirrhosis. Metabolism (1999) 1.48
Glucagon-like peptide-1 receptor agonists versus insulin in inadequately controlled patients with type 2 diabetes mellitus: a meta-analysis of clinical trials. Diabetes Obes Metab (2011) 1.47
Somatostatin suppresses secretin and pancreatic exocrine secretion. Science (1975) 1.45
Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest (1993) 1.45
A 10-year survey of nutritional support in a surgical ICU: 1986-1995. Nutrition (1997) 1.44
Epinephrine secretion, hypoglycemia unawareness, and diabetic autonomic neuropathy. Ann Intern Med (1994) 1.41
Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Metab (2001) 1.41
Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy. Ann Intern Med (1982) 1.41
Body fat and sympathetic nerve activity in healthy subjects. Circulation (1994) 1.38
Hepatic ketogenesis and gluconeogenesis in humans. J Clin Invest (1974) 1.37
A reappraisal of caloric requirements in healthy women. Am J Clin Nutr (1986) 1.35
Severe insulin-induced hypoglycemia associated with deficiencies in the release of counterregulatory hormones. N Engl J Med (1981) 1.30
A sensitive double antibody radioimmunoassay for human growth hormone (HGH): levels of serum HGH following rapid tolbutamide infusion. Diabetologia (1967) 1.29
Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest (1994) 1.28
Energy metabolism in feasting and fasting. Adv Exp Med Biol (1979) 1.24
Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men. Diabetes Metab (2010) 1.24
Malonyl-CoA and AMP-activated protein kinase (AMPK): possible links between insulin resistance in muscle and early endothelial cell damage in diabetes. Biochem Soc Trans (2003) 1.24
Regulation of body weight in humans. Physiol Rev (1999) 1.22
Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia (2001) 1.20
Increased human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells induced by ethanol: potential immunopathogenic mechanisms. J Infect Dis (1996) 1.19
Carbohydrate oxidation and storage in obese non-insulin-dependent diabetic patients. Effects of improving glycemic control. Diabetes (1983) 1.18
Thermic effect of food in lean and obese men. J Clin Invest (1988) 1.18
Rapid intravenous sodium acetoacetate infusion in man. Metabolic and kinetic responses. J Clin Invest (1973) 1.15
Effect of hyperinsulinemia on urea pool size and substrate oxidation rates. Diabetes (1988) 1.14
Preparation and specificity of antiserum to synthetic secretin and its use in a radioimmunoassay (RIA). Endocrinology (1973) 1.13
Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36. J Clin Endocrinol Metab (2006) 1.13
Effects of intraduodenal amino acids, fatty acids, and sugars on secretin concentrations. Gastroenterology (1975) 1.12
Exenatide prevents fat-induced insulin resistance and raises adiponectin expression and plasma levels. Diabetes Obes Metab (2007) 1.11
Ketosis of starvation: a revisit and new perspectives. Clin Endocrinol Metab (1983) 1.08
Effects of fructose and glucose overfeeding on hepatic insulin sensitivity and intrahepatic lipids in healthy humans. Obesity (Silver Spring) (2013) 1.07
A test of the hypothesis that the rate of fall in glucose concentration triggers counterregulatory hormonal responses in man. Diabetes (1977) 1.07
Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections. Infect Immun (2000) 1.07
Comparison of thermogenic effect of fructose and glucose in normal humans. Am J Physiol (1986) 1.06
Effect of carbohydrate overfeeding on whole body macronutrient metabolism and expression of lipogenic enzymes in adipose tissue of lean and overweight humans. Int J Obes Relat Metab Disord (2004) 1.05
Elevated serum human growth hormone and decreased serum insulin in prediabetic males after intravenous tolbutamide and glucose. J Clin Invest (1968) 1.04
Inhibition of central amylin signaling increases food intake and body adiposity in rats. Endocrinology (2001) 1.03
Effects of therapy on the nature and quantity of fuels oxidized during diabetic ketoacidosis. Diabetes (1980) 1.02
The effects of catechin rich teas and caffeine on energy expenditure and fat oxidation: a meta-analysis. Obes Rev (2011) 1.02
Dietary zinc deficiency fuels esophageal cancer development by inducing a distinct inflammatory signature. Oncogene (2011) 1.00
Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis. J Clin Invest (1981) 1.00
Ethanol causes acute inhibition of carbohydrate, fat, and protein oxidation and insulin resistance. J Clin Invest (1988) 1.00
Glucose metabolism in cachectic patients with colorectal cancer. Cancer Res (1984) 0.99
Energy metabolism in sepsis and injury. Nutrition (1997) 0.99
Quantitation of glycolysis and skeletal muscle glycogen synthesis in humans. Am J Physiol (1993) 0.99
Effects of fructose on hepatic glucose metabolism in humans. Am J Physiol Endocrinol Metab (2000) 0.98
Mechanisms of action of beta-glucan in postprandial glucose metabolism in healthy men. Eur J Clin Nutr (2001) 0.98
Effect of major hepatectomy on glucose and lactate metabolism. Ann Surg (1999) 0.98
Splanchnic somatostatin: a hormonal regulator of nutrient homeostasis. Science (1980) 0.98
Effects of intraduodenal administration of HCl and glucose on circulating immunoreactive secretin and insulin concentrations. J Clin Invest (1974) 0.97
How to get the most out of the trainee year. Br Med J (Clin Res Ed) (1982) 0.97
Treatment of autonomic neuropathy with a somatostatin analogue SMS-201-995. Lancet (1986) 0.96
Acetone metabolism during diabetic ketoacidosis. Diabetes (1982) 0.96
Prevention of postprandial hypotension with somatostatin. Ann Intern Med (1985) 0.96
In vivo and in vitro effects of antiinsulin receptor antibodies. J Clin Endocrinol Metab (1984) 0.95
Fish oil prevents the adrenal activation elicited by mental stress in healthy men. Diabetes Metab (2003) 0.95
Monitoring metabolic control in diabetic outpatients with glycosylated hemoglobin. Ann Intern Med (1980) 0.95
Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995. N Engl J Med (1986) 0.95
Endogenous glucose production, gluconeogenesis and liver glycogen concentration in obese non-diabetic patients. Diabetologia (1997) 0.95
Increased plasma levels of nesfatin-1 in patients with newly diagnosed type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes (2011) 0.95
Intestinal absorption in patients after cardiac surgery. Crit Care Med (2000) 0.94
Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest (1983) 0.94
Effects of estradiol on lipoprotein lipase activity and lipid availability in exercised male rats. J Appl Physiol (1985) (1994) 0.94
Effects of infused fructose on endogenous glucose production, gluconeogenesis, and glycogen metabolism. Am J Physiol (1994) 0.93
Suppression of insulin-induced sympathetic activation and vasodilation by dexamethasone in humans. Circulation (1993) 0.93
Fuel metabolism during pregnancy. Semin Reprod Endocrinol (1999) 0.93
Relapsing polychondritis with insulin resistance and antibodies to cartilage. Am J Med (1973) 0.93
Screening for personality disorders in a nonclinical population. J Pers Disord (1999) 0.93
Longitudinal study of carbohydrate metabolism in healthy obese pregnant women. Diabetes Care (1997) 0.93
Insulin-induced sympathetic activation and vasodilation in skeletal muscle. Effects of insulin resistance in lean subjects. Diabetes (1995) 0.91